GSK.L

GSK plc LSE · GSK.L

$1,893.00 +11.00 (+0.58%)

Pullback · -0.89σ Grade C

+ Compare Open in Sniper

Mkt cap $76.5B

P/E 13.5

Day $1850.50 – $1913.50

52wk $1690.00 – $2282.00

Avg vol 8.3M

Beta 0.30

Div yld 3.59%

Next earnings 2026-07-28

Quick read

At a glance

GSK.L last traded at $1,893, up 0.6% on the day; that's in the middle part of its 52-week range ($1,690–$2,282). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.

The next scheduled earnings report (2026-07-28) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.

A quick snapshot built from the data on this page — not investment advice. Always do your own research.

Today's read

Grading desk →

Price is stretched slightly below its normal range — a light stretch — early days, worth watching.

Long C

Setup score 32 / 100

Price is stretched slightly below its normal range — a light stretch — early days, worth watching.

· KC1 lower stretch — light dip
· RSI hook from oversold (42)
· Volume surge 2.2x avg

Technical read: KC1 lower, -0.89 ATR from EMA21 · no notable pattern

What it means: Price is stretched slightly below its normal range — a light stretch — early days, worth watching. The trigger bar shows no standout candle signal yet.

Score split: chart signals 32 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 32 pts

Cycle position 14

Momentum 6

Volume 6

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

Short —

Setup score 18 / 100

Price is sitting close to its normal range — not meaningfully overheated yet.

· Stochastic bear cross
· Volume 2.2x avg (no candle alignment)
· Chop regime — mean-reversion favored both ways

Technical read: below KC1 upper, -0.89 ATR from EMA21 · no notable pattern

What it means: Price is sitting close to its normal range — not meaningfully overheated yet. The trigger bar shows no standout candle signal yet.

Score split: chart signals 18 / 80 · news & fundamentals checks 0 / 20 — chart signals carry most of the grade.

How this grade was earned

total 18 pts

Cycle position 6

Momentum 3

Volume 3

Market fit 6

Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.

132-Day Trend Zones

Full chart →

21 EMA +1 ATR +2 ATR −2 ATR

—

O — H — L — C —

— —

Key statistics

All statistics →

GSK.L is a $76.5 billion company, priced at 13× last year's earnings, and it moves more calmly than the market (beta 0.3).

Market cap $76.5B

P/E ttm 13.5

Beta 0.30

52w range $1690.00 – $2282.00

Avg volume 8.3M

Dividend yield 3.59%

Sector Healthcare

Next earnings 2026-07-28

52-week range · today's price

$1690.00$2282.00

More on GSK.L

Earnings

See more →

Last reported: 2026-04-29
EPS (act / est): 0.47 / 0.44
Surprise: +4.9%
Next report: 2026-07-28

About

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respirato…